Impact on intracortical myelination trajectory of long acting injection versus oral risperidone in first-episode schizophrenia.
about
Impact of long-acting injectable antipsychotics on medication adherence and clinical, functional, and economic outcomes of schizophreniaBrain involvement in Alström syndrome.Myelination, oligodendrocytes, and serious mental illness.Alterations of Myelin Content in Parkinson's Disease: A Cross-Sectional Neuroimaging StudyThe early longitudinal course of cognitive deficits in schizophrenia.A critical review of pro-cognitive drug targets in psychosis: convergence on myelination and inflammation.The role of long-acting injectable antipsychotics in schizophrenia: a critical appraisal.Assessing intracortical myelin in the living human brain using myelinated cortical thicknessBiomarker investigations related to pathophysiological pathways in schizophrenia and psychosis.Combined white matter imaging suggests myelination defects in visual processing regions in schizophrenia.Long-Acting Injectable Risperidone for Relapse Prevention and Control of Breakthrough Symptoms After a Recent First Episode of Schizophrenia. A Randomized Clinical Trial.The Use of Continuous Treatment Versus Placebo or Intermittent Treatment Strategies in Stabilized Patients with Schizophrenia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials with First- and Second-Generation Antipsychotics.Pharmacological treatment of schizophrenia with comorbid substance use disorder.Aripiprazole once-monthly long-acting injectable for the treatment of schizophrenia.Altered intracortical myelin staining in the dorsolateral prefrontal cortex in severe mental illness.Baseline Demographics and Characteristics From a Paliperidone Palmitate Study in Subjects with Recent-Onset Schizophrenia or Schizophreniform Disorder.Age-related mapping of intracortical myelin from late adolescence to middle adulthood using T1 -weighted MRI.Identifying patients and clinical scenarios for use of long-acting injectable antipsychotics - expert consensus survey part 1.
P2860
Q24597701-E7880050-D44C-451C-BE71-FD56717A68E1Q30457679-F843E491-EF58-43F6-B1AA-E6043897861EQ30838265-918E98AC-C8DE-4E0E-B2C3-A101582A1DEAQ31134906-082A402E-8BA7-42F0-84ED-4C062F92CC95Q33844544-47051B12-537B-48F3-B29D-3BA235CE055EQ34405264-DC917D26-689D-41C9-AA53-F9E7FE7C365CQ34418847-3452ABF8-BF45-41CD-BD3D-8409DFFDD8E2Q36191848-DAAE5300-C209-44F8-9ACD-942D4BFA1119Q36955877-5C51F930-3E4E-449A-A5B8-4785091D832FQ37017646-8C0BEB89-A61F-445A-86FB-17AF50FA98D4Q37341552-AACBF4EF-730F-4C69-B7A9-15E32D90DD6AQ38570636-63ADA40E-6572-474F-BF05-9490E042E2BFQ38658672-C809B143-1E0D-41E0-9C8C-9A406675613EQ38728652-A7F83C72-2A34-4B5C-9638-0EF4D2700B71Q38821182-3C64B130-29D3-4422-9083-B981E5C22AF2Q41280874-EBF4D1CA-A72D-4190-BFA6-FD8CB29EF76CQ47734822-9A85C081-8A5A-4970-AAAF-B54A1E2AAB50Q55364906-F72BFC01-C97C-4B0F-8126-5F9BA9E0E7BE
P2860
Impact on intracortical myelination trajectory of long acting injection versus oral risperidone in first-episode schizophrenia.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Impact on intracortical myelin ...... n first-episode schizophrenia.
@ast
Impact on intracortical myelin ...... n first-episode schizophrenia.
@en
type
label
Impact on intracortical myelin ...... n first-episode schizophrenia.
@ast
Impact on intracortical myelin ...... n first-episode schizophrenia.
@en
prefLabel
Impact on intracortical myelin ...... n first-episode schizophrenia.
@ast
Impact on intracortical myelin ...... n first-episode schizophrenia.
@en
P2093
P2860
P1476
Impact on intracortical myelin ...... n first-episode schizophrenia.
@en
P2093
Alexander J Couvrette
Chetan P Amar
Erika P Raven
George Bartzokis
John S Luo
Joseph Ventura
Kenneth L Subotnik
Laurie R Casaus
Nicole R Detore
P2860
P304
P356
10.1016/J.SCHRES.2012.06.036
P407
P577
2012-07-17T00:00:00Z